Prescription Practices/Third Party Payer
In 2006, Gateway Health, a Medicaid plan, saw the increase in the number of infants with neonatal abstinence syndrome as a warning sign that a significant amount of women of childbearing years were dealing with an opiate addiction. Gateway collaborated with the Pennsylvania Department of Human Services, obstetricians, neonatologists, behavioral, and social services providers to create and fund a model of coordinated care.
When the use of buprenorphine was determined to be a safe method of medication-assisted treatment (MAT) during pregnancy, Gateway recognized that there were an inadequate number of MAT providers, that most community providers of buprenorphine were not knowledgeable about the needs of pregnant women, and that pregnant women on Medicaid needed care coordinated due to challenges with transportation, child care, and multiple types of care required. Specialized MAT clinics for pregnant women were developed to provide prenatal care, MAT, behavioral health and substance use counseling, social service support, and training for additional providers to expand the model of care. Additionally, the clinics would allow for conversion from street drugs in the outpatient setting, reducing healthcare costs and increasing patient acceptance. Gateway created innovative ideas for contracting including a PM/PM model, allowing for a more comprehensive and co-located approach to services. Gateway's maternity case managers have direct contact with each site, thereby increasing communication. Gateway continues to expand this model of care so that more women and their families receive the care they need when they need it most.
This session is accredited for the following accreditation types: CME, CNE, CPE, APA, AAFP, AAHCPAD*, NAADAC*, ASWB*
*State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.